SEC Form 13F

Aquamarine Financial (Cayman) Ltd 13F Holdings

Inspect Aquamarine Financial (Cayman) Ltd's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-08-13T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-08-13
Reported value
$1,811,322,571
Positions
17

Read this manager's filing book

Step 1 of 3

Disclosed positions

Aquamarine Financial (Cayman) Ltd: source evidence dated 2026-08-13T03:59:59.999Z.

Issuer
BANCO BRADESCO S A
Ticker
BBD
Class
SP ADR PFD NEW
Reported value
$649,020,291
Reported amount
186,948,134
Unit
SH
Option
None
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

What was reported for this quarter?

13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.

SEC 13F-HR: 0001493152-26-037413
What you should see

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Step 3 of 3

Browse institutional filings

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Browse institutional filings
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Disclosed positions

See the complete disclosed positions

Scroll sideways to compare all columns. Select a heading to sort.

BANCO BRADESCO S ABBDSP ADR PFD NEW$649,020,291186,948,134SHNone
YPF SOCIEDAD ANONIMAYPFSPON ADR CL D$565,871,78612,444,948SHNone
GRUPO FINANCIERO GALICIA S.AGGALSPONSORED ADR$175,883,6673,515,564SHNone
NU HLDGS LTDNUORD SHS CL A$119,941,2178,977,636SHNone
BANCO MACRO S ABMASPON ADR B$78,006,149842,490SHNone
GERDAU SAGGBSPON ADR REP PFD$67,573,73116,726,171SHNone
BANCO SANTANDER BRASIL S ABSBRADS REP 1 UNIT$54,569,46610,394,184SHNone
BANCO BBVA ARGENTINA S ABBARSPONSORED ADS$33,358,1401,701,078SHNone
PAGAYA TECHNOLOGIES LTDPGYCL A NEW$32,324,5641,771,209SHNone
ORAMED PHARMACEUTICALS INCORMPCOM NEW$12,083,5622,512,175SHNone
ALPHA TAU MEDICAL LTDUnresolvedORDINARY SHARES$9,076,483721,501SHNone
COSAN S ACSANADS$6,039,0842,096,904SHNone
INNOVIZ TECHNOLOGIES LTDUnresolvedSHS$4,436,9965,828,949SHNone
PULSENMORE LTDUnresolvedORD SHS$1,951,897338,541SHNone
TRANSPORTADORA DE GAS DEL SUTGSSPONSORED ADS B$882,86229,696SHNone
CENTRAL PUERTO S ACEPUSPONSORED ADR$287,00619,314SHNone
VALENS SEMICONDUCTOR LTDUnresolved*W EXP 09/30/202$15,670559,653SHNone

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 4 positions lack a resolved ticker and 0 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.